Back to results
US 2013/0253031 A1Published application
Methods of treating mixed dyslipidemia
AssigneeAmarin Pharmaceuticals Ireland Limited
InventorsIan Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Mehar Manku
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.
Claims14
A method of treating hypertriglyceridemia in a subject comprising, administering to the subject daily a statin and about 4 g of ethyl eicosapentaenoate to effect a reduction in fasting triglycerides and LDL-C relative to subjects having hypertriglyceridemia who are receiving a statin without said ethyl eicosapentaenoate.
Dependencies are inferred from the claim text.